The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients

Elisa Teyssou; Cathia Soulie; Benoit Visseaux; Sidonie Lambert-Niclot; Valentine Ferre; Stephane Marot; Aude Jary; Sophie Sayon; Karen Zafilaza; Valentin Leducq; Aurelie Schnuriger; Basma Abdi; Marc Wirdern; Nadira Houhou-Fidouh; Charlotte Charpentier; Laurence Morand-Joubert; Sonia Burrel; Diane Descamps; Vincent Calvez; Anne-Genevieve Marcelin.
Preprint en Inglés | PREPRINT-MEDRXIV | ID: ppmedrxiv-21253498

Documentos relacionados

  1. Comparison of performance of LIAISON SARS-CoV-2 antigen assay with RT-PCR during the Omicron wave.
  2. RT-PCR negative COVID-19.
  3. The Life of SARS-CoV-2 Inside Cells: Replication-Transcription Complex Assembly and Function.
  4. Epidemiological and clinical insights from SARS-CoV-2 RT-PCR crossing threshold values, France, January to November 2020.
  5. Comparison of Reverse-Transcription Polymerase Chain Reaction Cycle Threshold Values From Respiratory Specimens in Symptomatic and Asymptomatic Children With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
  6. Comparative study of SmartAmp assay and reverse transcription-polymerase chain reaction by saliva specimen for the diagnosing COVID-19.
  7. Comparison of a novel antigen detection test with reverse transcription polymerase chain reaction assay for laboratory diagnosis of SARS-CoV-2 infection.
  8. A method comparison study of the high throughput automated HISCL® SARS-CoV-2 antigen assay using nasopharyngeal swab samples from symptomatic and asymptomatic subjects against conventional RT-PCR.
  9. A Simple Reverse Transcriptase PCR Melting-Temperature Assay To Rapidly Screen for Widely Circulating SARS-CoV-2 Variants.
  10. Clinical validation of quantitative SARS-CoV-2 antigen assays to estimate SARS-CoV-2 viral loads in nasopharyngeal swabs.